Cytek Biosciences builds cell analysis instruments. The Fremont, California-based company develops flow cytometry and single-cell analysis platforms, anchored by its Full Spectrum Profiling (FSP) technology. Its hardware lineup includes the Aurora, Aurora CS, and Northern Lights systems - all designed to push deeper into cellular data at scale.
The customer base is technical and demanding: pharmaceutical companies, contract research organizations, academic research institutions, and labs working in immunology, oncology, and cell therapy. These are environments where instrument uptime, data integrity, and reproducibility aren't aspirational - they're the minimum viable product. The company's stated mission centers on enabling scientists to obtain deep biological insights rapidly and efficiently.
For anyone operating at the intersection of life sciences and engineering, Cytek represents a specific kind of challenge: building and maintaining systems where the data pipeline - from laser excitation through spectral unmixing to downstream analysis - has to be bulletproof. The threat model here isn't adversarial actors in the traditional sense; it's instrument drift, calibration failure, and software bugs that could compromise research data or clinical study outcomes across a global installed base.
